Agitation in Alzheimer's disease: Novel outcome measures reflecting the International Psychogeriatric Association (IPA) agitation criteria-Reference-Cited by-同舟云学术

Agitation in Alzheimer's disease: Novel outcome measures reflecting the International Psychogeriatric Association (IPA) agitation criteria

Published:2021-06-16 Issue:10 Volume:17 Page:1687-1697
ISSN:1552-5260
Container-title:Alzheimer's & Dementia
language:en
Short-container-title:Alzheimer's & Dementia

Author:

De Mauleon Adelaide¹,Ismail Zahinoor²,Rosenberg Paul³,Miller David⁴,Cantet Christelle¹⁵,O'Gorman Cedric⁶,Vellas Bruno¹,Lyketsos Constantine³,Soto Maria¹

Affiliation:

1. Gerontopole Alzheimer Clinical and Research Center University Hospital of Toulouse (CHU Toulouse) URM 1295 CERPOP Inserm UPS Université de Toulouse Toulouse France

2. Psychiatry Clinical Neurosciences and Community Health Sciences Hotchkiss Brain Institute and O'Brien Institute for Public Health University of Calgary Calgary Alberta Canada

3. Department of Psychiatry and Behavioral Sciences Johns Hopkins School of Medicine Baltimore Maryland USA

4. Signant Health Blue Bell Pennsylvania USA

5. USMR Epidemiology and Public Health Department University Hospital of Toulouse (CHU Toulouse) Toulouse France

6. Axsome Therapeutics New York New York USA

Publisher

Wiley

Subject

Psychiatry and Mental health,Cellular and Molecular Neuroscience,Geriatrics and Gerontology,Clinical Neurology,Developmental Neuroscience,Health Policy,Epidemiology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/alz.12335

Reference32 articles.

1. Neuropsychiatric signs and symptoms of Alzheimer's disease: New treatment paradigms

2. Neuropsychiatric symptoms in Alzheimer's disease

3. Effect of Citalopram on Agitation in Alzheimer Disease

4. Progress in treatment development for neuropsychiatric symptoms in Alzheimer's disease: focus on agitation and aggression. A report from the EU/US/CTAD task force;Soto M;J Prev Alzheimers Dis,2015

5. Conceptualization of agitation: results based on the Cohen‐Mansfield agitation inventory and the agitation behavior mapping instrument;Cohen‐Mansfield J;Int Psychogeriatr,1997

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Brexpiprazole for Agitation Associated With Dementia Due to Alzheimer's Disease;Journal of the American Medical Directors Association;2024-10

2. Defining a clinically meaningful within-patient change threshold for the Cohen-Mansfield Agitation Inventory in Alzheimer’s dementia;Frontiers in Neurology;2024-07-23

3. Detecting agitation and aggression in persons living with dementia: a systematic review of diagnostic accuracy;BMC Geriatrics;2024-06-26

4. Neuropsychiatric symptoms profile and markers of Alzheimer disease–type pathology in patients with Lewy body dementias;Brain Research;2024-06

5. Nanolithium, a New Treatment Approach to Alzheimer’s Disease: A Review of Existing Evidence and Clinical Perspectives;The Journal of Prevention of Alzheimer's Disease;2024